Movement Alert|JD HEALTH Intraday Rise 3.28% in Regular Trading, Supported by Sector Rebound and Solid Interim Results

Market Focus10-30

On October 30, JD HEALTH recorded an Intraday Rise of 3.28% in Regular Trading, with the stock trading at HK$37.3 and turnover of HK$51.96 million.

The latest market update points to a broader rebound in Hong Kong-listed healthcare and large-cap technology names, with JD HEALTH moving in tandem with that sector strength. In the same Internet & Direct Marketing Retail group, MEITUAN-W rose 4.12%, PA GOODDOCTOR rose 2.84%, JD-SW rose 2.49%, ALI HEALTH rose 2.36%, and BABA-W rose 1.25%.

Fundamentally, the company previously reported interim revenue of RMB40.9 billion, up 15.9%, while Non-IFRS operating profit rose 40.3% to RMB3.5 billion, lifting operating margin to 8.5%. Its September monthly share report also showed no material change in share capital, indicating a stable capital structure. These factors help explain why the stock has participated in the sector’s recovery.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment